蛋白名稱:IL1B人重組蛋白，10139-HNAE

蛋白構(gòu)建:A DNA sequence encoding the mature form of human IL1β (NP_000567.1) (Ala 117-Ser 269) was expressed with a N-terminal Met.

表達(dá)宿主:E. coli

蛋白純度:≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.

蛋白活性:

1.Measured by its ability to induce Interferon gamma secretion by human natural killer lymphoma NK-92 cells. The * for this effect is typically 0.2-2 ng/mL.

2.Recombinant Human IL1R1 Protein, hFc Tag (Cat. No. 10126-H02H) captured on Protein A chip, can bind Recombinant Human IL-1 beta Protein (Cat. No. 10139-HNAE) with an affinity constant of 0.942 nM as determined in an SPR assay (Biacore T200) (Routinely tested).

蛋白內(nèi)毒素:< 5 EU per mg of the protein as determined by the LAL method.

預(yù)測N端:Met

蛋白分子量:The recombinant human IL1β consisting of 154 amino acids migrates with an apparent molecular mass of 17 kDa as estimated in SDS-PAGE under reducing conditions.

蛋白NP號(hào):NP_000567.1

蛋白氨基酸序列:Ala117-Ser269

蛋白標(biāo)簽:Native

歡迎去義翹神州網(wǎng)查看IL1B人重組蛋白，10139-HNAE詳細(xì)信息。網(wǎng)址：https://cn.sinobiological.com/recombinant-proteins/human-il-1-beta-10139-hnae

義翹神州研發(fā)團(tuán)隊(duì)擁有多年的重組蛋白研發(fā)經(jīng)驗(yàn)。多年來，我們的團(tuán)隊(duì)已開發(fā)出超過9300余種重組蛋白，涵蓋免疫檢查點(diǎn)、抗體藥物靶點(diǎn)、CAR-T細(xì)胞治療靶點(diǎn)、Fc受體、流感病毒蛋白以及細(xì)胞因子等熱門研究領(lǐng)域。義翹神州重組蛋白具有高純度、高生物活性和低內(nèi)毒素水平等特性，可為生物藥靶點(diǎn)發(fā)現(xiàn)、蛋白質(zhì)結(jié)構(gòu)和功能分析、細(xì)胞療法和重組酶酶學(xué)性質(zhì)等科學(xué)研究提供支持。

歡迎小伙伴來咨詢哦!  請注明來源、姓名，單位！

關(guān)注義翹神州或添加微信“sinobio2023"進(jìn)行聯(lián)系！